Ontruzant (trastuzumab-dttb) is used to treat stomach and
breast cancer. Ontruzant is a biosimilar for
herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Ontruzant may be covered by your Medicare or insurance plan.